Skip to content

Comparison of wound dressing solutions, TCDO vs SOS, in wound healing

Efficacy And Safety Of Tetrachlorodecaoxide In Comparison With Super-Oxidized Solution, In Wound Healing.

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/09/009625
Enrollment
Unknown
Registered
2017-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ulcers (wounds)

Interventions

Intervention1: Tetrachlorodecaoxide: Topical wound healing agent Control Intervention1: Superoxidized Solution: Topical wound healing agent

Sponsors

Grant Medical College Sir Jamshedjee Jeejeebhoy Group of Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: adult patients aged more than 18 years presenting with ulcers of varied etiology including pressure ulcers, venous ulcers, diabetic foot ulcers, post traumatic wounds, post-operative complicated/non healing wounds, amputation stumps, burn wounds, abscesses, ulcers due to Fournierâ??s gangrene.

Exclusion criteria

Exclusion criteria: pregnant or breast-feeding women, patients who are simultaneously participating in another clinical trial with an unlicensed drug or who have done so within one month period, patients not willing to participate in study, patients with a known hypersensitivity to any of the drugs, and moribund patients.

Design outcomes

Primary

MeasureTime frame
wound healing, objectively assessed by measurement of wound size; and by PUSH Tool for wound size, wound exudation and wound tissue type.Timepoint: day 7 14 21 28

Secondary

MeasureTime frame
subjective improvement in pain using VAS scale; recording adverse eventsTimepoint: day 7 14 21 28

Countries

India

Contacts

Public ContactDr Romil Parikh

Grant Medical College, Sir Jamshedjee Jeejeebhoy Group of Hospitals

romil.r.parikh@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026